Difference Gel Electrophoresis (DiGE) to profile changes in the nuclear proteome that occur 25 after stable expression of EBNA1 in the EBV-negative NPC cell line, CNE2. We found that 26 EBNA1 consistently altered the levels of a small percentage of the nuclear proteins.
INTRODUCTION
also performed to minimize labelling-dependent bias. Equal amounts of protein from all four 120 samples (for each fraction) were pooled to form an internal control; 50 μg of which was labelled 121 with Cy2 to serve as a reference for spot normalization and comparison between gels. The 
125
First dimensional isoelectric focusing (IEF) of Cy3, Cy5 and Cy2-labelled protein 126 samples was performed on an Ettan IPGPhor II electrophoresis system (GE Healthcare) using 127 13-cm Immobiline Drystrips, pH 3-11 NL(GE Healthcare). IEF was performed at 20°C with the 128 following parameters: 50 µA/strip for 14 h of rehydration, stepped to 500 V for 3.5 kV·h, 129 gradient stepped to 1000 V for 0.8 kV·h, gradient stepped 8,000 V for 14 kV·h, and 8,000 V for separation was done by13% SDS-PAGE at 4°C with 15 min at 10 mA followed by 5 hrs at 30 134 mA. The 2D gels were scanned on a Typhoon scanner (GE Healthcare) at a 100-µm resolution 135 with λexcitation/ λemission values of 488/520, 532/580, and 633/670 nm for Cy2, Cy3, and Cy5, 136 respectively, then were analysed using DeCyder Software (v6.5; GE Healthcare). Gels were were used to analyze 300 µg of unlabeled protein samples as described above (150 µg each from 146 CNE2 and CNE2E samples). The 2D gels were then stained overnight using Colloidal
147
Coomassie dye (17% ammonium sulphate, 3% ortho-phosphoric acid, 34% methanol, 0.1% G-148 250). Spots of interest were manually excised by matching the preparative 2D gels to analytical 149 gels. These were subjected to overnight in-gel trypsin digestion using 13 ng of trypsin (Sigma) 150 per µL of gel dissolved in 50% acetonitrile, 25 mM ammonium bicarbonate. Peptides were 151 extracted in 16 µM ammonium bicarbonate, then 0.02% formic acid, then 40% acetonitrile for 10 152 minutes each (repeated twice). Mass spectrometry on extracted pepetides was performed by the 153 Advanced Protein Technology Centre (Hospital for Sick Children, Toronto, ON, Canada), using 8 an on-line liquid chromatography-tandem mass spectrometry setup using an Agilent 1100
155
Capillary LC system (Palo Alto, CA) fitted to a LTQ ion trap mass spectrometer (Thermo
156
Electron, San Jose, CA). A C18 pre-column (100 µm i.d. x 5.0 cm length) and a µLC analytical 157 column (75 µm x 10 cm) that also served as a µESI emitter were used for the separation of the 158 digested proteins. Identity of peptides was determined using Mascot (Matrix Science, London,
159
UK; version Mascot) and validated using Scaffold (version Scaffold_2_06_00, Proteome
160
Software Inc., Portland, OR). Some spots were also analyzed by MALDI-TOF mass 161 spectrometry after in-gel trypsin hydrolysis. The peptides were purified and analyzed by 162 MALDI-TOF mass spectrometry using a cyano-4-hydroxycinnamic acid matrix (Sigma) on a
163
Voyager DE-STR instrument (Applied Biosystems). Identification of the proteins using these 164 mass fingerprinting data was carried out using the ProFound software. which an equal mixture of the samples was labelled with a third dye (cy2). In total, 4 gels were 239 analyzed for each nuclear fraction. Fig. 1A illustrates the strategy used in detail. For protein 240 identification, preparative gels were run with unlabelled samples and stained with Colloidal
241
Coomassie dye, and protein spots of interest were excised and subjected to mass spectrometry. at least a 1.5 fold difference (Fig 1B) . Fig. 2A shows a representative 2D gel generated from the suggesting that EBNA1 may affect the ability of EBV-transformed tumour cells to metastasize. maspin levels in the nuclear extract more so than in the whole cell extract and decreased Prx1 295 more in the whole cell extract than in the nuclear extract. Note that whole cell extracts not only 296 differ from nuclear extracts in containing cytoplasm, but also contain additional nuclear proteins 297 that leach out of the nucleus upon cell lysis. To ensure that the EBNA1 siRNA was not affecting 298 proteins independent of EBNA1, we also compared the specific protein levels in CNE2 cells 299 after siGFP and siEBNA1 treatments (Fig. 4B ). However, in the absence of EBNA1, siEBNA1 300 treatment had no effect on the whole cell or nuclear levels of any of the proteins in question.
301
Therefore the EBNA1 depletion results further confirm the findings from the 2D-DiGE analysis. regulation in these cells was found to decrease NOX2 but not NOX1 levels (Fig. 7E ) and to 361 result in a small but statistically significant decrease in ROS levels (Fig. 7F) antigens (37).
395
The DiGE results showed that EBNA1 up-regulated the nuclear levels of three different 
407
In addition to effects on Nm23-H1, we found that EBNA1 also increased the nuclear 408 level of maspin and stathmin 1, both of which have been found to contribute to metastases. EBNA1 may also contribute to deregulation of stathmin 1 in NPC.
428
A second group of proteins that we found to be upregulated by EBNA1 are involved in were not commonly reported (1, 7, 9, 53).
447
The observation of EBNA1-induced antioxidants prompted us to ask if EBNA1 also 
466
In conclusion, our proteomics study showed that EBNA1 affects the levels of a small 
